Cargando…

The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP.

Prostaglandins (PGs) have numerous cardiovascular and inflammatory effects. Cyclooxygenase (COX), which exists as COX-1 and COX-2 isoforms, is the first enzyme in the pathway in which arachidonic acid is converted to PGs. Prostaglandin E2 (PGE2) exerts a variety of biological activities for the main...

Descripción completa

Detalles Bibliográficos
Autores principales: Akarasereenont, P, Techatrisak, K, Chotewuttakorn, S, Thaworn, A
Formato: Texto
Lenguaje:English
Publicado: 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781816/
https://www.ncbi.nlm.nih.gov/pubmed/10815617
_version_ 1782131980248285184
author Akarasereenont, P
Techatrisak, K
Chotewuttakorn, S
Thaworn, A
author_facet Akarasereenont, P
Techatrisak, K
Chotewuttakorn, S
Thaworn, A
author_sort Akarasereenont, P
collection PubMed
description Prostaglandins (PGs) have numerous cardiovascular and inflammatory effects. Cyclooxygenase (COX), which exists as COX-1 and COX-2 isoforms, is the first enzyme in the pathway in which arachidonic acid is converted to PGs. Prostaglandin E2 (PGE2) exerts a variety of biological activities for the maintenance of local homeostasis in the body. Elucidation of PGE2 involvement in the signalling molecules such as COX could lead to potential therapeutic interventions. Here, we have investigated the effects of PGE2 on the induction of COX-2 in human umbilical vein endothelial cells (HUVEC) treated with interleukin-1beta (IL-1beta 1 ng/ml). COX activity was measured by the production of 6-keto-PGF1alpha, PGE2, PGF2alpha and thromboxane B2 (TXB2) in the presence of exogenous arachidonic acids (10 microM for 10 min) using enzyme immunoassay (EIA). COX-1 and COX-2 protein was measured by immunoblotting using specific antibody. Untreated HUVEC contained only COX-1 protein while IL-1beta treated HUVEC contained COX-1 and COX-2 protein. PGE2 (3 microM for 24h) did not affect on COX activity and protein in untreated HUVEC. Interestingly, PGE2 (3 microM for 24h) can inhibit COX-2 protein, but not COX-1 protein, expressed in HUVEC treated with IL-1beta. This inhibition was reversed by coincubation with forskolin (100 microM). The increased COX activity in HUVEC treated with IL-1beta was also inhibited by PGE2 (0.03, 0.3 and 3 microM for 24h) in a dose-dependent manner. Similarly, forskolin (10, 50 or 100 microM) can also reverse the inhibition of PGE2 on increased COX activity in IL-1beta treated HUVEC. The results suggested that (i) PGE2 can initiate negative feedback regulation in the induction of COX-2 elicited by IL-1beta in endothelial cells, (ii) the inhibition of PGE2 on COX-2 protein and activity in IL-1beta treated HUVEC is mediated by cAMP and (iii) the therapeutic use of PGE2 in the condition which COX-2 has been involved may have different roles.
format Text
id pubmed-1781816
institution National Center for Biotechnology Information
language English
publishDate 1999
record_format MEDLINE/PubMed
spelling pubmed-17818162007-01-25 The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP. Akarasereenont, P Techatrisak, K Chotewuttakorn, S Thaworn, A Mediators Inflamm Research Article Prostaglandins (PGs) have numerous cardiovascular and inflammatory effects. Cyclooxygenase (COX), which exists as COX-1 and COX-2 isoforms, is the first enzyme in the pathway in which arachidonic acid is converted to PGs. Prostaglandin E2 (PGE2) exerts a variety of biological activities for the maintenance of local homeostasis in the body. Elucidation of PGE2 involvement in the signalling molecules such as COX could lead to potential therapeutic interventions. Here, we have investigated the effects of PGE2 on the induction of COX-2 in human umbilical vein endothelial cells (HUVEC) treated with interleukin-1beta (IL-1beta 1 ng/ml). COX activity was measured by the production of 6-keto-PGF1alpha, PGE2, PGF2alpha and thromboxane B2 (TXB2) in the presence of exogenous arachidonic acids (10 microM for 10 min) using enzyme immunoassay (EIA). COX-1 and COX-2 protein was measured by immunoblotting using specific antibody. Untreated HUVEC contained only COX-1 protein while IL-1beta treated HUVEC contained COX-1 and COX-2 protein. PGE2 (3 microM for 24h) did not affect on COX activity and protein in untreated HUVEC. Interestingly, PGE2 (3 microM for 24h) can inhibit COX-2 protein, but not COX-1 protein, expressed in HUVEC treated with IL-1beta. This inhibition was reversed by coincubation with forskolin (100 microM). The increased COX activity in HUVEC treated with IL-1beta was also inhibited by PGE2 (0.03, 0.3 and 3 microM for 24h) in a dose-dependent manner. Similarly, forskolin (10, 50 or 100 microM) can also reverse the inhibition of PGE2 on increased COX activity in IL-1beta treated HUVEC. The results suggested that (i) PGE2 can initiate negative feedback regulation in the induction of COX-2 elicited by IL-1beta in endothelial cells, (ii) the inhibition of PGE2 on COX-2 protein and activity in IL-1beta treated HUVEC is mediated by cAMP and (iii) the therapeutic use of PGE2 in the condition which COX-2 has been involved may have different roles. 1999 /pmc/articles/PMC1781816/ /pubmed/10815617 Text en
spellingShingle Research Article
Akarasereenont, P
Techatrisak, K
Chotewuttakorn, S
Thaworn, A
The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP.
title The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP.
title_full The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP.
title_fullStr The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP.
title_full_unstemmed The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP.
title_short The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP.
title_sort induction of cyclooxygenase-2 in il-1beta-treated endothelial cells is inhibited by prostaglandin e2 through camp.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781816/
https://www.ncbi.nlm.nih.gov/pubmed/10815617
work_keys_str_mv AT akarasereenontp theinductionofcyclooxygenase2inil1betatreatedendothelialcellsisinhibitedbyprostaglandine2throughcamp
AT techatrisakk theinductionofcyclooxygenase2inil1betatreatedendothelialcellsisinhibitedbyprostaglandine2throughcamp
AT chotewuttakorns theinductionofcyclooxygenase2inil1betatreatedendothelialcellsisinhibitedbyprostaglandine2throughcamp
AT thaworna theinductionofcyclooxygenase2inil1betatreatedendothelialcellsisinhibitedbyprostaglandine2throughcamp
AT akarasereenontp inductionofcyclooxygenase2inil1betatreatedendothelialcellsisinhibitedbyprostaglandine2throughcamp
AT techatrisakk inductionofcyclooxygenase2inil1betatreatedendothelialcellsisinhibitedbyprostaglandine2throughcamp
AT chotewuttakorns inductionofcyclooxygenase2inil1betatreatedendothelialcellsisinhibitedbyprostaglandine2throughcamp
AT thaworna inductionofcyclooxygenase2inil1betatreatedendothelialcellsisinhibitedbyprostaglandine2throughcamp